Valneva reports nine-month results
VALN Stock | USD 3.87 0.18 4.44% |
About 61% of Valneva SE's investor base is looking to short. The analysis of the overall investor sentiment regarding Valneva SE ADR suggests that many traders are alarmed. Valneva SE's investing sentiment overview a quick insight into current market opportunities from investing in Valneva SE ADR. Many technical investors use Valneva SE ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Valneva |
Valneva reports nine-month 2024 financial results with a net profit of 24.7 million and revenue of 116.6M.
Read at seekingalpha.com
Valneva SE Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Valneva SE can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Valneva SE Fundamental Analysis
We analyze Valneva SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Valneva SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Valneva SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Valneva SE is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Valneva SE ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Valneva SE stock to make a market-neutral strategy. Peer analysis of Valneva SE could also be used in its relative valuation, which is a method of valuing Valneva SE by comparing valuation metrics with similar companies.
Peers
Valneva SE Related Equities
SAGE | Sage Therapeutic | 5.85 | ||||
MLYS | Mineralys Therapeutics, | 5.64 | ||||
NUVB | Nuvation Bio | 2.76 | ||||
SLS | Sellas Life | 2.65 | ||||
TIL | Instil Bio | 2.49 | ||||
CNTB | Connect Biopharma | 1.89 | ||||
TYRA | Tyra Biosciences | 1.15 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
OPT | Opthea | 0.54 | ||||
ELYM | Eliem Therapeutics | 0.31 | ||||
STOK | Stoke Therapeutics | 0.33 | ||||
INBX | Inhibrx | 1.18 | ||||
GLUE | Monte Rosa | 1.35 | ||||
CGEM | Cullinan Oncology | 2.08 | ||||
THRD | Third Harmonic | 2.66 | ||||
NCNA | NuCana PLC | 3.08 | ||||
RLYB | Rallybio Corp | 3.42 | ||||
EWTX | Edgewise Therapeutics | 4.42 | ||||
CCCC | C4 Therapeutics | 5.49 | ||||
RVMD | Revolution Medicines | 10.46 |
Check out Valneva SE Hype Analysis, Valneva SE Correlation and Valneva SE Performance. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.13) | Revenue Per Share 2.3 | Quarterly Revenue Growth 0.204 | Return On Assets (0.11) | Return On Equity (0.04) |
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.